Joel Lewis
President and CEO at Galectin Therapeutics · 20 reported transactions in 1 company · latest trade Jan 6, 2026
Their trades
Sold | Jan 6, 2026 | Jan 6, 2026 close $3.45 → Oct 28, 2026 close $3.54. S&P 500 +11.6% over the same days. | ||
Sold | Jan 5, 2026 | Jan 5, 2026 close $3.88 → Oct 28, 2026 close $3.54. S&P 500 +12.3% over the same days. | ||
Sold | Jan 2, 2026 | Jan 2, 2026 close $4.05 → Oct 28, 2026 close $3.54. S&P 500 +13.1% over the same days. | ||
Sold | Dec 17, 2025 | Dec 17, 2025 close $6.47 → Oct 28, 2026 close $3.54. S&P 500 +15.0% over the same days. | ||
Sold | Nov 18, 2025 | Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $6.00 → Oct 28, 2026 close $3.54. S&P 500 +16.0% over the same days. |
$134.9K
Jan 6, 2026 close $3.45 → Oct 28, 2026 close $3.54. S&P 500 +11.6% over the same days.
$108.3K
Jan 5, 2026 close $3.88 → Oct 28, 2026 close $3.54. S&P 500 +12.3% over the same days.
$77.9K
Jan 2, 2026 close $4.05 → Oct 28, 2026 close $3.54. S&P 500 +13.1% over the same days.
$55.2K
Dec 17, 2025 close $6.47 → Oct 28, 2026 close $3.54. S&P 500 +15.0% over the same days.
$41.7K
Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days.
$94.6K
Nov 17, 2025 close $6.00 → Oct 28, 2026 close $3.54. S&P 500 +16.0% over the same days.